Humacyte regains Nasdaq minimum bid price compliance as of June 5, 2026

Humacyte, Inc.

Nasdaq notified Humacyte that closing bid price was below $1.00 for 30 consecutive days as of May 1, 2026.
Company had until November 2, 2026 to regain compliance by closing at $1.00+ for 10 consecutive days.
On June 5, 2026, Nasdaq confirmed compliance and considers the matter closed.
Common stock (HUMA) and warrants (HUMAW) remain listed on The Nasdaq Global Select Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.